Eleanor Kotas

York, ENG YO105NQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Evidence on the effectiveness of policies promoting price transparency - A systematic review.

Evidence on the effectiveness of policies promoting price transparency - A systematic review.

Journal: Health policy (Amsterdam, Netherlands)
Published: April 06, 2021

A systematic review of health state utility values for thyroid cancer.

A systematic review of health state utility values for thyroid cancer.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: October 07, 2020

Which are the most sensitive search filters to identify randomized controlled trials in MEDLINE?

Which are the most sensitive search filters to identify randomized controlled trials in MEDLINE?

Journal: Journal of the Medical Library Association : JMLA
Published: October 05, 2020

A technical review of three clinical trials register resources indicates where improvements to the search interfaces are needed.

A technical review of three clinical trials register resources indicates where improvements to the search interfaces are needed.

Journal: Research synthesis methods
Published: June 30, 2020

Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.

Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation.

Journal: Health technology assessment (Winchester, England)
Published: June 27, 2020

Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Journal: PharmacoEconomics - open
Published: April 16, 2020

Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.

Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.

Journal: Health technology assessment (Winchester, England)
Published: January 15, 2020

Advancing mental health equality: a mapping review of interventions, economic evaluations and barriers and facilitators.

Advancing mental health equality: a mapping review of interventions, economic evaluations and barriers and facilitators.

Journal: Systematic reviews
Published: September 27, 2019

Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Journal: PharmacoEconomics - open
Published: June 27, 2019

Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation.

Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation.

Journal: PloS one
Published: June 20, 2019

Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Journal: PharmacoEconomics - open
Published: February 12, 2019

Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Journal: PharmacoEconomics
Published: October 18, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026